| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |




From the Divisions of Blood and Marrow Transplantation* and Immunology and Rheumatology,
Department of Medicine, and the Department of Pediatrics,¶ Stanford University, Stanford, California; the Department of Medicine,
Knappschaftskrankenhaus, Ruhr-Universitaet Bochum, Bochum, Germany; and the Institute of Pathology,
Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
Little is known about adoptive transfer of allogeneic ex vivo expanded dendritic cells (eDCs). We investigated the trafficking pattern of eDCs in mice after allogeneic bone marrow transplantation by using bioluminescence imaging. eDCs were expanded from bone marrow precursors in the presence of GM-CSF, interleukin-4, and Flt3L and retrovirally transduced to express luciferase (luc) and green fluorescence protein (gfp). Flow cytometry showed polyclonal DC populations after expansion that consisted of CD11c+CD11b+ and CD11cCD11b+ cells that co-expressed CD40, CD80, CD86, and MHCII. eDCs were functional in mixed lymphocyte reactions and produced tumor necrosis factor-
on phytohemagglutinin stimulation. The eDCs were then injected intravenously into BALB/c recipient mice that had received allogeneic bone marrow transplantation 6 weeks previously. On day 1 after transfer, eDCs were detected by bioluminescence imaging throughout the lungs and spleen. In the later course, signals were observed throughout thymus, lower abdomen, and spleen throughout a period of more than 42 days. Immunofluorescence microscopy confirmed CD11c positivity on the gfp+ donor cells, which localized in T-cell zones of mesenteric lymph nodes, Peyers patches, spleen, and thymus. These findings are important for adoptive immunotherapies because they indicate that eDCs migrate efficiently in vivo and are capable of surviving long term.
This article has been cited by other articles:
![]() |
K. L.L. Habets, G. H.M. van Puijvelde, L. M. van Duivenvoorde, E. J.A. van Wanrooij, P. de Vos, J.-W. C. Tervaert, T. J.C. van Berkel, R. E.M. Toes, and J. Kuiper Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice Cardiovasc Res, February 1, 2010; 85(3): 622 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hochmeister, M. Zeitelhofer, J. Bauer, E.-M. Nicolussi, M.-T. Fischer, B. Heinke, E. Selzer, H. Lassmann, and M. Bradl After Injection into the Striatum, in Vitro-Differentiated Microglia- and Bone Marrow-Derived Dendritic Cells Can Leave the Central Nervous System via the Blood Stream Am. J. Pathol., December 1, 2008; 173(6): 1669 - 1681. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. Noh, Y. T. Lim, and B. H. Chung Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals FASEB J, November 1, 2008; 22(11): 3908 - 3918. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Akins and P. Dubey Noninvasive Imaging of Cell-Mediated Therapy for Treatment of Cancer J. Nucl. Med., June 1, 2008; 49(Suppl_2): 180S - 195S. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |